The Supreme Court argument over subsidies that help millions of people afford their health insurance suggests that the Obama administration has two chances to attract one critical vote.
FDA Approves Opdivo for the Treatment of Patients with Previously Treated Metastatic Squamous Non-Small Cell Lung CancerMarch 4, 2015 11:04 pm | News | Comments
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has...
Audience members look on at a tribal marijuana conference for tribal governments considering...
he U.S. Supreme Court this week hears a challenge to President Barack Obama's health care...
Pfizer has announced that the European Commission approved an expanded indication for the use of Prevenar 13 for the prevention of pneumonia caused by the 13 pneumococcal serotypes in the vaccine in adults aged 18 years and older.
Ten-year-old Alexis Carey has a rare but intractable form of epilepsy, Dravet Syndrome. The genetic disease causes severe and multiple seizures, which often leave parents guessing if the terror of watching their child seize up will pass or turn fatal.
Bipartisan Act would preserve FDA user fees from sequestration.
Attempts to quarantine health workers returning from Ebola-stricken West Africa were a mistake, the president's bioethics advisers said Thursday.
Federal health officials have approved a new antibiotic combination to treat several hard-to-treat infections. The drug contains two ingredients, cephalosporin and avibactam, designed to help fight antibiotic-resistant bacteria.
A recent report found that recalls of products overseen by the U.S. Food and Drug Administration fell during the final quarter of 2014 but the number of affected units increased.
President Barack Obama's health secretary told Congress Tuesday that she has no administrative actions available to fix the "massive damage to our health care system" that would result should the Supreme Court invalidate federal subsidies that help millions of Americans buy health care coverage.
A prominent California lawmaker will again seek to place warning labels on soft drinks and other beverages containing added sugar, while industry groups gear up to combat the effort.
The U.S. Food and Drug Administration has approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Multiple myeloma is a form of blood cancer that arises from plasma cells, a type of white blood cell, found in bone marrow.
Sagent Pharmaceuticals has announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of Atracurium Besylate Injection, USP, 100mg/10mL multi-dose vials (NDC 25021-672-10) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Sagent.
Millions of people could lose health insurance subsidies in the coming months if the Supreme Court sides with opponents of President Barack Obama's health care overhaul. And one thing was clear this weekend as the nation's governors gathered in Washington: Many of the states that could be affected are not prepared for the potential fallout.
Federal health officials are easing access to DNA tests used to screen parents for devastating genetic disorders that can be passed on to their children. The surprise announcement offers a path forward for Google-backed genetic testing firm 23andMe, which previously clashed with regulators over its direct-to-consumer technology.
Florida has eclipsed California to become the state with the highest number of consumers buying health coverage through new insurance markets under the Affordable Care Act, according to federal statistics released Wednesday.
Hundreds of products are being pulled from store shelves after traces of peanut were found in cumin spice — a life-threatening danger to some people with peanut allergies.
More than 11 million people signed up for subsidized private health insurance under President Barack Obama's law this year, the White House announced Tuesday evening. But that preliminary estimate — 11.4 million people — comes with a couple of asterisks.
Eisai has announced that the FDA approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).
The FDA has cleared the Cepheid Xpert MTB/RIF Assay to help physicians determine if patients with suspected tuberculosis (TB) can be removed from airborne infection isolation.
Thousands of people signing up for health insurance this weekend may not realize it, but their coverage under President Barack Obama's law could be short-lived.
Hospira has announced a voluntary recall of ketorolac tromethamine injection, USP in the United States and Singapore due to potential particulate. The presence of particulate has been confirmed through a customer report of visible, floating particulate identified in glass fliptop vials.
With rampant diabetes and obesity, Mississippi and West Virginia have struggled with health crises. Yet when it comes to getting children vaccinated, these states don't mess around.
FDA Approves Genentech’s Lucentis® for Treatment of Diabetic Retinopathy in People With Diabetic Macular EdemaFebruary 9, 2015 7:12 am | News | Comments
Genentech, a member of the Roche Group announced that the FDA approved Lucentis® for the treatment of diabetic retinopathy (DR) in people with diabetic macular edema (DME). DME impacts nearly 750,000 Americans, about 10 percent of people with DR.
A plan by three Republican lawmakers for replacing President Barack Obama's health care overhaul would leave Americans with less coverage and higher costs than the landmark law they want to repeal, Democrats said Thursday.
California lawmakers are proposing legislation that would require parents to vaccinate all school children unless a child's health is in danger, joining only two other states with such stringent restrictions.
A bill introduced this week in the state Senate would require Nevada preteens to be immunized against meningitis and the sexually transmitted human papillomavirus before they enroll in public or private school or daycare, potentially raising Nevada's below-average HPV vaccination rate.
Closer and more frequent communications with the FDA are likely the main factors leading to a shorter approval time for breakthrough drug therapies, according to Fitch Ratings. Breakthrough therapy approvals more than tripled in 2014 versus 2013.
- Page 1